Cardiomyocyte PDGFR-β signaling is an essential component of the mouse cardiac response to load-induced stress-Reference-Cited by-同舟云学术

Cardiomyocyte PDGFR-β signaling is an essential component of the mouse cardiac response to load-induced stress

Published:2010-02-01 Issue:2 Volume:120 Page:472-484
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Chintalgattu Vishnu,Ai Di,Langley Robert R.,Zhang Jianhu,Bankson James A.,Shih Tiffany L.,Reddy Anilkumar K.,Coombes Kevin R.,Daher Iyad N.,Pati Shibani,Patel Shalin S.,Pocius Jennifer S.,Taffet George E.,Buja L. Maximillian,Entman Mark L.,Khakoo Aarif Y.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference56 articles.

1. Targeting the Platelet-Derived Growth Factor Receptor in Antivascular Therapy for Human Ovarian Carcinoma

2. Involvement of platelet-derived growth factor in disease: development of specific antagonists

3. Effects of Blocking Platelet-Derived Growth Factor-Receptor Signaling in a Mouse Model of Experimental Prostate Cancer Bone Metastases

4. Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma

Cited by 163 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel insights into cardiovascular toxicity of cancer targeted and immune therapies: Beyond ischemia with non-obstructive coronary arteries (INOCA);American Heart Journal Plus: Cardiology Research and Practice;2024-04

2. In the Rat Hippocampus, Pilocarpine-Induced Status Epilepticus Is Associated with Reactive Glia and Concomitant Increased Expression of CD31, PDGFRβ, and Collagen IV in Endothelial Cells and Pericytes of the Blood–Brain Barrier;International Journal of Molecular Sciences;2024-01-30

3. mtADENet: A novel interpretable method integrating multiple types of network-based inference approaches for prediction of adverse drug events;Computers in Biology and Medicine;2024-01

4. Drug-induced cardiotoxicity;Public Health and Toxicology Issues Drug Research, Volume 2;2024

5. Identification of a Selective FLT3 Inhibitor with Low Activity against VEGFR, FGFR, PDGFR, c‐KIT, and RET Anti‐Targets;ChemMedChem;2023-12-07